Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Hospital Acquired Infection Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Hospital Acquired Infection Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Hospital Acquired Infection Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Aridis Pharmaceuticals, Inc
Eli Lilly and Company
Merck & Co, Inc
F Hoffmann-La Roche Ltd
AstraZeneca plc
Abbott Laboratories
Johnson & Johnson Services, Inc
Pfizer Inc
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Astellas Pharma Inc
Daiichi Sankyo, Inc
Cipla Inc
Cepheid
Bayer AG
By Type:
Antibacterial
Antiviral
Antifungal Treatment
Antiparasitic
Antiprotozoal
Anti-TB Treatment
By End-User:
Urinary Tract Infection
Ventilator-Associated Pneumonia
Bloodstream Infection
Surgical Site Infection
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hospital Acquired Infection Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antibacterial from 2016 to 2027
-
1.3.2 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiviral from 2016 to 2027
-
1.3.3 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antifungal Treatment from 2016 to 2027
-
1.3.4 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiparasitic from 2016 to 2027
-
1.3.5 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiprotozoal from 2016 to 2027
-
1.3.6 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Anti-TB Treatment from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Urinary Tract Infection from 2016 to 2027
-
1.4.2 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Ventilator-Associated Pneumonia from 2016 to 2027
-
1.4.3 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Bloodstream Infection from 2016 to 2027
-
1.4.4 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Surgical Site Infection from 2016 to 2027
-
1.4.5 USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Hospital Acquired Infection Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hospital Acquired Infection Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Antibacterial
-
3.4.2 Market Size and Growth Rate of Antiviral
-
3.4.3 Market Size and Growth Rate of Antifungal Treatment
-
3.4.4 Market Size and Growth Rate of Antiparasitic
-
3.4.5 Market Size and Growth Rate of Antiprotozoal
-
3.4.6 Market Size and Growth Rate of Anti-TB Treatment
4 Segmentation of Hospital Acquired Infection Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hospital Acquired Infection Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Hospital Acquired Infection Treatment in Urinary Tract Infection
-
4.4.2 Market Size and Growth Rate of Hospital Acquired Infection Treatment in Ventilator-Associated Pneumonia
-
4.4.3 Market Size and Growth Rate of Hospital Acquired Infection Treatment in Bloodstream Infection
-
4.4.4 Market Size and Growth Rate of Hospital Acquired Infection Treatment in Surgical Site Infection
-
4.4.5 Market Size and Growth Rate of Hospital Acquired Infection Treatment in Others
5 Market Analysis by Regions
-
5.1 USA Hospital Acquired Infection Treatment Production Analysis by Regions
-
5.2 USA Hospital Acquired Infection Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Hospital Acquired Infection Treatment Landscape Analysis
-
6.1 West USA Hospital Acquired Infection Treatment Landscape Analysis by Major Types
-
6.2 West USA Hospital Acquired Infection Treatment Landscape Analysis by Major End-Users
7 South USA Hospital Acquired Infection Treatment Landscape Analysis
-
7.1 South USA Hospital Acquired Infection Treatment Landscape Analysis by Major Types
-
7.2 South USA Hospital Acquired Infection Treatment Landscape Analysis by Major End-Users
8 Middle West USA Hospital Acquired Infection Treatment Landscape Analysis
-
8.1 Middle West USA Hospital Acquired Infection Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Hospital Acquired Infection Treatment Landscape Analysis by Major End-Users
9 Northeast USA Hospital Acquired Infection Treatment Landscape Analysis
-
9.1 Northeast USA Hospital Acquired Infection Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Hospital Acquired Infection Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Aridis Pharmaceuticals, Inc
-
10.1.1 Aridis Pharmaceuticals, Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Eli Lilly and Company
-
10.2.1 Eli Lilly and Company Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Merck & Co, Inc
-
10.3.1 Merck & Co, Inc Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 F Hoffmann-La Roche Ltd
-
10.4.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AstraZeneca plc
-
10.5.1 AstraZeneca plc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Abbott Laboratories
-
10.6.1 Abbott Laboratories Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Johnson & Johnson Services, Inc
-
10.7.1 Johnson & Johnson Services, Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Pfizer Inc
-
10.8.1 Pfizer Inc Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Bristol-Myers Squibb Company
-
10.9.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 GlaxoSmithKline plc
-
10.10.1 GlaxoSmithKline plc Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Astellas Pharma Inc
-
10.11.1 Astellas Pharma Inc Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Daiichi Sankyo, Inc
-
10.12.1 Daiichi Sankyo, Inc Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Cipla Inc
-
10.13.1 Cipla Inc Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Cepheid
-
10.14.1 Cepheid Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Bayer AG
-
10.15.1 Bayer AG Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antibacterial from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiviral from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antifungal Treatment from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiparasitic from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Antiprotozoal from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Anti-TB Treatment from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Urinary Tract Infection from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Ventilator-Associated Pneumonia from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Bloodstream Infection from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Surgical Site Infection from 2016 to 2027
-
Figure USA Hospital Acquired Infection Treatment Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Hospital Acquired Infection Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Hospital Acquired Infection Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hospital Acquired Infection Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Hospital Acquired Infection Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antibacterial
-
Figure Market Size and Growth Rate of Antiviral
-
Figure Market Size and Growth Rate of Antifungal Treatment
-
Figure Market Size and Growth Rate of Antiparasitic
-
Figure Market Size and Growth Rate of Antiprotozoal
-
Figure Market Size and Growth Rate of Anti-TB Treatment
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Hospital Acquired Infection Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Hospital Acquired Infection Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Urinary Tract Infection
-
Figure Market Size and Growth Rate of Ventilator-Associated Pneumonia
-
Figure Market Size and Growth Rate of Bloodstream Infection
-
Figure Market Size and Growth Rate of Surgical Site Infection
-
Figure Market Size and Growth Rate of Others
-
Table USA Hospital Acquired Infection Treatment Production by Regions
-
Table USA Hospital Acquired Infection Treatment Production Share by Regions
-
Figure USA Hospital Acquired Infection Treatment Production Share by Regions in 2016
-
Figure USA Hospital Acquired Infection Treatment Production Share by Regions in 2021
-
Figure USA Hospital Acquired Infection Treatment Production Share by Regions in 2027
-
Table USA Hospital Acquired Infection Treatment Consumption by Regions
-
Table USA Hospital Acquired Infection Treatment Consumption Share by Regions
-
Figure USA Hospital Acquired Infection Treatment Consumption Share by Regions in 2016
-
Figure USA Hospital Acquired Infection Treatment Consumption Share by Regions in 2021
-
Figure USA Hospital Acquired Infection Treatment Consumption Share by Regions in 2027
-
Table West USA Hospital Acquired Infection Treatment Consumption by Types from 2016 to 2027
-
Table West USA Hospital Acquired Infection Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2016
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2021
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2027
-
Table West USA Hospital Acquired Infection Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Hospital Acquired Infection Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2016
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2021
-
Figure West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2027
-
Table South USA Hospital Acquired Infection Treatment Consumption by Types from 2016 to 2027
-
Table South USA Hospital Acquired Infection Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by Types in 2016
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by Types in 2021
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by Types in 2027
-
Table South USA Hospital Acquired Infection Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Hospital Acquired Infection Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2016
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2021
-
Figure South USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Hospital Acquired Infection Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Hospital Acquired Infection Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by Types in 2027
-
Table Middle West USA Hospital Acquired Infection Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Hospital Acquired Infection Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Hospital Acquired Infection Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Hospital Acquired Infection Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by Types in 2027
-
Table Northeast USA Hospital Acquired Infection Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Hospital Acquired Infection Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Hospital Acquired Infection Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Aridis Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aridis Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Aridis Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Aridis Pharmaceuticals, Inc
-
Table Product and Service Introduction of Aridis Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Merck & Co, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
-
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
-
Figure Revenue and Market Share Analysis of Merck & Co, Inc
-
Table Product and Service Introduction of Merck & Co, Inc
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of AstraZeneca plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc
-
Figure Sales and Growth Rate Analysis of AstraZeneca plc
-
Figure Revenue and Market Share Analysis of AstraZeneca plc
-
Table Product and Service Introduction of AstraZeneca plc
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Johnson & Johnson Services, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services, Inc
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson Services, Inc
-
Figure Revenue and Market Share Analysis of Johnson & Johnson Services, Inc
-
Table Product and Service Introduction of Johnson & Johnson Services, Inc
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Astellas Pharma Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc
-
Figure Sales and Growth Rate Analysis of Astellas Pharma Inc
-
Figure Revenue and Market Share Analysis of Astellas Pharma Inc
-
Table Product and Service Introduction of Astellas Pharma Inc
-
Table Company Profile and Development Status of Daiichi Sankyo, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo, Inc
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo, Inc
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo, Inc
-
Table Product and Service Introduction of Daiichi Sankyo, Inc
-
Table Company Profile and Development Status of Cipla Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Inc
-
Figure Sales and Growth Rate Analysis of Cipla Inc
-
Figure Revenue and Market Share Analysis of Cipla Inc
-
Table Product and Service Introduction of Cipla Inc
-
Table Company Profile and Development Status of Cepheid
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid
-
Figure Sales and Growth Rate Analysis of Cepheid
-
Figure Revenue and Market Share Analysis of Cepheid
-
Table Product and Service Introduction of Cepheid
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
